Skip to main content
. 2025 Oct 2;30:111. doi: 10.1186/s11658-025-00789-5

Table 3.

Application of different cell death regulators in TNBC

Cell death pathway involved Drugs Mechanism Reference
Apoptosis ABT-737 ABT-737 attaches to Bcl-2/Bcl-xL/Bcl-w, stopping them from interacting with Bax and Bak, which in turn lifts the suppression of apoptosis [395]
LCL161 LCL161 blocks IAPs, lifting their inhibition of apoptosis, and alters the tumor microenvironment by drawing macrophages to the tumor location [396]
APR-246 When p53 is activated, it increases the levels of pro-apoptotic proteins, such as Bax and PUMA, and decreases the levels of anti-apoptotic proteins such as Bcl-2 and Bcl-xL [397, 398]
Pembrolizumab Blocking the PD-1/PD-L1 immune checkpoint activates CTLs and triggers cancer cell apoptosis via T cell-mediated cytotoxicity [376, 399]
Epothilone B Induction of cancer cell apoptosis via the PI3K/AKT/mTOR signaling pathway enhances the apoptotic effects of ABT-737 [286]
Pyroptosis Cisplatin Activation of the MEG3/NLRP3/caspase-1/GSDMD pathway in TNBC induces pyroptosis to exert anti-tumor effects [383]
AZU1 Regulation of the pNF-κB/NLRP3/caspase-1/GSDMD axis in TNBC promotes pyroptosis [400]
MCC950 By binding to the NACHT domain of NLRP3, its oligomerization and activation are prevented, which inhibits its function and makes TNBC cells more sensitive to PTX [279]
CY-09 Inhibiting the Walker B motif of NLRP3 reduces its activity, which in turn suppresses IL-1β/EMT/Wnt/β-catenin signaling and makes TNBC cells more sensitive to GDC-0941 [401]
OLT1177 Inhibition of NLRP3-induced IL-1β prevents the progression of TNBC [402]
Autophgy CQ Preventing the fusion of autophagosomes with lysosomes results in the buildup of autophagosomes inside the cell, which encourages the death of tumor cells [288, 289]
Toosendanin Raising lysosomal pH inhibits autolysosome maturation, thereby suppressing late-stage autophagy in TNBC cells [403]
circEGFR The translocation of annexin A2 (ANXA2) to the plasma membrane in TNBC cells facilitates the dissociation of the transcription factor TFEB from the ANXA2-TFEB complex, subsequently promoting autophagy. Concurrently, circEGFR acts as a competing endogenous RNA (ceRNA) by directly binding to miR-224-5p, thereby inhibiting its expression and mitigating the suppression of autophagy mediated by the miR-224-5p/ATG13/ULK1 axis [404]
UBC12 Enhancing TRIM25 sumoylation boosts its interaction with TFEB, which promotes the transcription and activation of genes related to autophagy [405]
Necroptosis ZBP1 When glucose is deprived, mtDNA is released into the cytoplasm, where it attaches to ZBP1, triggering MLKL activation in a manner dependent on Bcl-2 family proteins and NOXA [406]
Curcuma longa Enhanced expression of TRAIL under acidic conditions induces necroptotic apoptosis in a RIPK1- and RIPK3-dependent manner [407]
Ferroptosis Erastin Blocking System Xc- on the cell membrane lowers cystine absorption, which results in reduced GSH production inside the cell and weakened antioxidant defenses, thus encouraging lipid peroxidation and ferroptosis [218, 219]
Sulfasalazine Blocking VDAC in mitochondria impairs their function, leading to the release of iron ions and heightened oxidative stress [408, 409]
RSL3 Inhibition of GPX4 activity elevates intracellular lipid peroxidation levels, thereby promoting ferroptosis [292, 293]
Liproxstatin-1 In TNBC cells, the activation of cPLA2α leads to the activation of ACSL4, which facilitates the attachment of PUFAs to coenzyme A, thereby raising lipid peroxidation levels and inducing ferroptosis [410]
Eupaformosanin Ubiquitination of mutant p53 induces apoptosis and ferroptosis in TNBC cells [320]